Concourse Financial Group Securities, Inc. Zai Lab LTD Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share
Q2 2024 Jul 23, 2024	BUY	$13.72 - $21.55 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$15.95 - $26.8 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$22.97 - $30.58 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$22.72 - $31.49 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$22.72 - $31.49 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$25.3 - $39.67 $0 - $0
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$22.28 - $38.71 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$34.2 - $51.69 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$23.14 - $49.68 $0 - $0
Q1 2022 May 09, 2022	BUY	$27.77 - $64.4 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$54.9 - $105.21 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$105.0 - $178.37 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $0 - $0
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$81.94 - $135.34 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$48.82 - $82.53 $0 - $0
Q1 2020 May 13, 2020	BUY	$39.1 - $62.9 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$29.79 - $43.06 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$30.47 - $37.65 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$25.73 - $35.79 $0 - $0
Q1 2019 May 15, 2019	BUY	$21.71 - $31.54 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$14.95 - $24.72 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$17.8 - $25.35 $0 - $0

Others Institutions Holding ZLAB

# of Institutions

117

Shares Held

40.9M

Call Options Held

63.1K

Put Options Held

420K

Wellington Management Group LLP Boston, MA

7.12M
Shares

$150 Million
0.02% of portfolio
Janus Henderson Group PLC London, X0

6.53M
Shares

$138 Million
0.06% of portfolio
Capital World Investors Los Angeles, CA

5.31M
Shares

$112 Million
0.02% of portfolio
Woodline Partners LP San Francisco, CA

2.33M
Shares

$49.2 Million
0.41% of portfolio
Viking Global Investors LP

2.04M
Shares

$43 Million
0.14% of portfolio

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.06B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account